Dr. Louis DeGennaro, Leukemia and Lymphoma Society

Dr. Louis DeGennaro, Leukemia and Lymphoma Society

The Leukemia & Lymphoma Society (LLS), a New York-based charity, raises more than $300 million a year, with an average donation of just $75. Amassing their huge network of grassroots donors has helped the organization fund more than $1 billion for education and research to treat blood cancers.

In this interview from The Business of Giving, Dr. Louis DeGennaro, President & CEO of LLS,  talks about the charity’s success in attracting small donors to help deal with blood cancers–the third-leading cause of U.S. cancer deaths. He also discusses the organization’s research grants to speed development of promising therapies and their First Connection program that matches newly diagnosed patients and their families with survivors for personalized peer support.

Taking on Cancer at the Grass Roots

Taking on Cancer at the Grass Roots

The Leukemia & Lymphoma Society raises more than $300 million a year with an average donation of just $75. Amassing that huge network of grass-roots backers has helped the New York State-based charity pump more than $1 billion into research that has “led to the discovery of virtually every modern therapy used to treat the blood cancers,” says Louis DeGennaro, the society’s chief executive officer.  Blood cancers are the third-leading cause of U.S. cancer deaths.